Skip to content

GOENOMICS GmbH vs Seqera

GOENOMICS GmbH logo

GOENOMICS GmbH

World of biological sequences

4 employees · est. 2021 · Gottingen, Germany

VS
Seqera logo

Seqera

The Intelligent Engine for Life Sciences

121 employees · est. 2018 · Barcelona, Spain

Seqera is the older company (2021 vs 2018); Seqera is the larger of the two.

Side-by-Side Comparison

GOENOMICS GmbH Seqera
Founded
2021 2018 older
Headquarters
Gottingen, Germany Barcelona, Spain
Employees
4 121 larger
Industry
AI, Big Data, Biopharma Big Data, Computing, Life Sciences
Funding Stage
Non Equity Assistance Series A
Total Funding
Not tracked yet $33.10M
Funding Rounds
1 5
Services
Genome Annotation as a Service, Database and Search for Species Sequenced Worldwide, RNA-Seq Analysis, Search Platform for Genome Assemblies and Annotations Centralized Data Management, Workflow Orchestration, AI Tool Integration, Compliance and Audit Trail, Compute Cost Reduction
Target Customers
Biotechnology Companies, Academic Researchers, Plant and Animal Breeding Industry, Genomics Research Institutions Bioinformaticians, Lab Scientists, Research Teams, Biopharmaceutical Companies, Clinical Diagnostics Organizations
Taxonomy
Genome AnnotationGenomicsBioinformaticsPharmaceutical IndustryAgricultural BiotechnologyGenome Data Analysis +8 Life_sciencesGenomicsBiotechCloud_computingData_analysisOpen_source_technology +9
Website
goenomics.com seqera.io
GOENOMICS GmbH logo

About GOENOMICS GmbH

GOENOMICS GmbH is a German startup with a mission to provide genome annotations to aid agriculture, biotech, and academia in understanding and developing genomic traits for improved plants and fungi. This is crucial for securing the global food supply by enhancing characteristics such as heat resist...

Seqera logo

About Seqera

Seqera, established in 2018 and headquartered in Spain, is pioneering solutions in Big Data, Computing, and Life Sciences. The company’s mission, succinctly captured in its slogan, "The Intelligent Engine for Life Sciences," is to streamline complex data analysis pipelines within the cloud environme...

Also comparing in this category

Comparing more than these two?

Get GOENOMICS GmbH, Seqera and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does GOENOMICS GmbH compare?

A PDF of GOENOMICS GmbH and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

GOENOMICS GmbH was founded in 2021, based in Gottingen, Germany, with 4 employees. GOENOMICS GmbH is a German startup with a mission to provide genome annotations to aid agriculture, biotech, and academia in understanding and developing genomic traits for improved plants and fungi. Seqera was founded in 2018, based in Barcelona, Spain, with 121 employees. Seqera, established in 2018 and headquartered in Spain, is pioneering solutions in Big Data, Computing, and Life Sciences. The company’s mission, succinctly captured in its slogan, "The Intelligent En.
GOENOMICS GmbH has raised no disclosed funding and Seqera $33.10M. Latest stage: GOENOMICS GmbH Non Equity Assistance, Seqera Series A.
Both work in Big Data and Life Sciences and list genomics and bioinformatics among their focus areas.

Compare GOENOMICS GmbH with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at GOENOMICS GmbH on 14 Apr 2025, and Seqera on 14 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout